Stay updated on Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page has been updated to include the term 'Renal Cell Carcinoma (RCC)' and the EudraCT number for the study, while significant details about the study's purpose, inclusion and exclusion criteria, and previous revision information have been removed.
    Difference
    10%
    Check dated 2025-04-17T07:07:22.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 19, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T23:41:05.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3.
    Difference
    0.2%
    Check dated 2025-04-02T19:21:57.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has updated its date-related content, adding new dates in March and June 2025 while removing older dates from January and February 2025.
    Difference
    0.6%
    Check dated 2025-03-25T13:14:27.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:22:14.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The webpage has updated its service availability information, indicating that some NLM-NCBI services are experiencing heavy traffic, which may impact performance. Additionally, several dates have been updated to reflect future timelines.
    Difference
    2%
    Check dated 2025-02-10T09:51:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.